DCM Shriram Limited — Investor Meet, 28-07-2026: Analysts/Institutional Investor Meet/Con. Call Updates

DCM Shriram reported a solid Q1 FY27. Consolidated revenue grew 9% to Rs 3,564 Cr, PBDIT increased 12% to Rs 364 Cr, and effective normal PAT rose 29% to Rs 147 Cr. The Chemicals business showed resilience with strong demand and advancing integration projects. Sugar & Ethanol were stable, benefiting from a global sugar deficit. Fenesta Building Systems delivered healthy volume-driven growth. Agri businesses experienced temporary pressure due to an erratic monsoon. Management is focused on capacity ramp-up, value-chain integration, and disciplined capital allocation. Despite geopolitical and monsoon uncertainties, the company highlights a strong balance sheet and strategic progress.